ArticleThe European respiratory journal2021
Steroid use in elderly critically ill COVID-19 patients.
Open access · hybridAbstract readLetter
In one paragraph
Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs.Clinical and experimental medicine · 2024Pooled it
- Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.The Lancet. Respiratory medicine · 2022Trial
- Covid-19 a Strong Predictor of Hyperglycaemia Among Ugandan Patients: A Retrospective Study.Research square · 2026Article
- Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study.Journal of asthma and allergy · 2026Article
- Oxaliplatin-induced diffuse alveolar hemorrhage: A case report.World journal of clinical oncology · 2025Article
- Risk factors for in-hospital mortality in older patients with acute respiratory distress syndrome due to COVID-19: a retrospective cohort study.BMC geriatrics · 2024Observational
- Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study.Inflammopharmacology · 2024Article
- In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.Scientific reports · 2024Article
- Lack of racial and ethnic disparities in mortality in minority patients hospitalised with COVID-19 in a mid-Atlantic healthcare system.BMJ open respiratory research · 2024Article
- Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology.medRxiv : the preprint server for health sciences · 2024Article
- Article
- Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- Biomarkers for risk stratification and antibiotic stewardship in elderly patients.Aging clinical and experimental research · 2023Review
- Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients.Scientific reports · 2023Observational
- The impact of age on intensive care.Ageing research reviews · 2023Review
- A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients.Medicina intensiva · 2023Article
- Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19.Life (Basel, Switzerland) · 2022Article
- COVID-19 machine learning model predicts outcomes in older patients from various European countries, between pandemic waves, and in a cohort of Asian, African, and American patients.PLOS digital health · 2022Article
- From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?Biomedicines · 2022Review
- Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions.Critical care (London, England) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 20 institutions in 18 countries.
Christian JungMedical Faculty, Dept of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany christian.jung@med.uni-duesseldorf.de.ORCID https://orcid.org/0000-0001-8325-250X
Bernhard WernlyDept of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Jesper FjølnerDept of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
Raphael Romano BrunoMedical Faculty, Dept of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
David DudzinskiCardiac Intensive Care Unit, Massachusetts General Hospital, Boston, MA, USA.
Antonio ArtigasDept of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
Bernardo Bollen PintoDept of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.
Joerg C SchefoldDept of Intensive Care Medicine, Inselspital, Universitätsspital, University of Bern, Bern, Switzerland.
Georg WolffMedical Faculty, Dept of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Malte KelmMedical Faculty, Dept of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.ORCID https://orcid.org/0000-0003-0060-1052
Michael BeilDept of Medical Intensive Care, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Sviri SigalDept of Medical Intensive Care, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Peter Vernon van HeerdenDept of Anesthesia, Intensive Care and Pain Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Wojciech SzczeklikCenter for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.
Miroslaw Czuczwar2nd Dept of Anesthesiology and Intensive Care, Medical University of Lublin, Lublin, Poland.ORCID https://orcid.org/0000-0002-9025-6717
Muhammed ElhadiFaculty of Medicine, University of Tripoli, Tripoli, Libya.
Michael JoannidisDivision of Intensive Care and Emergency Medicine, Dept of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Sandra OeyenDept of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.
Tilemachos ZafeiridisIntensive Care Unit General Hospital of Larissa, Larissa, Greece.
Brian MarshMater Misericordiae University Hospital, Dublin, Ireland.
Finn H AndersenDept Of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway.
Rui MorenoUnidade de Cuidados Intensivos Neurocríticos e Trauma, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Faculdade de Ciências Médicas de Lisboa, Nova Médical School, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-9795-8316
Maurizio CecconiDept of Anaesthesia IRCCS, Instituto Clínico Humanitas, Humanitas University, Milan, Italy.ORCID https://orcid.org/0000-0002-4376-6538
Susannah LeaverGeneral Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK.
Ariane BoumendilSorbonne Universités, UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Paris, France.
Dylan W De LangeDept of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, The Netherlands.
Bertrand GuidetSorbonne Universités, UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Paris, France.
Hans FlaattenDept of Clinical Medicine, University of Bergen, Bergen, Norway.
and the COVIP study group
Heinrich Heine University Düsseldorf · DEHebrew University of Jerusalem · ILInserm · FRAarhus University Hospital · DKGhent University Hospital · BEHaukeland University Hospital · NOHospital de São José · PTHumanitas University · ITInnsbruck Medical University · ATJagiellonian University · PLMassachusetts General Hospital · USMater Misericordiae University Hospital · IEMedical University of Lublin · PLNorwegian University of Science and Technology · NOParacelsus Medical University · ATSt George’s University Hospitals NHS Foundation Trust · GBUniversitat Autònoma de Barcelona · ESUniversity Hospital of Geneva · CHUniversity Hospital of Larissa · GRUniversity of Bern · CH
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Critical IllnessAgedHumansRisk FactorsSARS-CoV-2SteroidsSteroids
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.